Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting (PG-APRE1)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Azienda Ospedaliera di Perugia.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Azienda Ospedaliera di Perugia
ClinicalTrials.gov Identifier:
NCT01088022
First received: March 16, 2010
Last updated: NA
Last verified: March 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: April 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)